Keene & Associates Inc. Has $371,000 Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Keene & Associates Inc. increased its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS) by 16.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,635 shares of the company’s stock after acquiring an additional 2,585 shares during the period. Keene & Associates Inc.’s holdings in Avanos Medical were worth $371,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Westwood Holdings Group Inc. grew its holdings in shares of Avanos Medical by 2.0% during the fourth quarter. Westwood Holdings Group Inc. now owns 2,151,091 shares of the company’s stock worth $48,249,000 after purchasing an additional 41,818 shares during the last quarter. William Blair Investment Management LLC grew its holdings in Avanos Medical by 16.8% during the 1st quarter. William Blair Investment Management LLC now owns 1,425,036 shares of the company’s stock worth $28,372,000 after acquiring an additional 204,826 shares during the last quarter. Paradice Investment Management LLC increased its position in Avanos Medical by 5.4% in the 2nd quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock valued at $26,791,000 after acquiring an additional 69,389 shares in the last quarter. Tributary Capital Management LLC increased its position in Avanos Medical by 7.5% in the 1st quarter. Tributary Capital Management LLC now owns 742,455 shares of the company’s stock valued at $14,782,000 after acquiring an additional 51,865 shares in the last quarter. Finally, Alberta Investment Management Corp raised its stake in shares of Avanos Medical by 16.6% in the fourth quarter. Alberta Investment Management Corp now owns 413,418 shares of the company’s stock worth $9,273,000 after acquiring an additional 58,826 shares during the last quarter. 95.17% of the stock is owned by institutional investors and hedge funds.

Avanos Medical Price Performance

AVNS opened at $24.00 on Monday. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.28 and a quick ratio of 1.49. The company’s 50 day simple moving average is $22.90 and its 200-day simple moving average is $20.67. Avanos Medical, Inc. has a one year low of $17.24 and a one year high of $24.77. The stock has a market capitalization of $1.10 billion, a P/E ratio of -18.05 and a beta of 0.91.

Avanos Medical (NYSE:AVNS) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.05. The firm had revenue of $171.70 million for the quarter, compared to analyst estimates of $170.67 million. Avanos Medical had a return on equity of 4.48% and a net margin of 1.13%. The business’s quarterly revenue was up 1.4% compared to the same quarter last year. During the same period last year, the company earned $0.24 EPS. Sell-side analysts anticipate that Avanos Medical, Inc. will post 1.39 earnings per share for the current fiscal year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.